Biomedical Innovation Program – moving innovations to market

For research scientists whose technical innovations have the potential to improve patient care, OHSU created the Biomedical Innovation Program. For four years now, BIP has been providing expertise and resources to steward innovations from the laboratory to clinical application through the process of commercialization. The program is a joint effort between Technology Transfer and Business Development and the Oregon Clinical and Translational Research Institute. To mark this occasion, the Oregon Clinical and Translational Research Institute sat down … Read More

Jan. 1: New F&A rates for non-clinical, industry-sponsored research

OHSU’s Facilities and Administrative rate for industry-sponsored research agreements will increase by 3%, effective January 1, 2017. The new rate will not apply to industry-sponsored clinical trials, federal awards such as SBIR/STTR awards, or ONPRC industry-sponsored agreements, but it will apply to all other industry-sponsored agreements entered into by Technology Transfer and Business Development on or after January 1, 2017. All currently funded projects will remain fixed at their awarded rate unless additional funding is … Read More

NCI seeking novel insights on infectious agents associated with cancer

It is well established that certain infectious agents play a role in cancer in humans. Worldwide, infections are linked to over %15 of cancers with much higher numbers in developing countries. The translational potential for this area of research is significant and may lead to new therapies and interventions. In order to support discoveries that could lead to better diagnosis, prevention and treatment of cancers, the National Cancer Institute is seeking input from the biomedical community with research … Read More

OHSU researchers open new field in cellular metabolism

A team of researchers from OHSU has developed a new biosensor for a molecule critical for healthy cellular function, nicotinamide adenine dinucleotide (NAD+). NAD+ is a coenzyme found in every cell, helping  to drive glucose metabolism. It is known to decline with advancing age, and this decline is thought to play a role in age-related diseases such as cancer, cardiovascular disease, and neurodegeneration. While NAD+ was discovered about 100 years ago, we still don’t know … Read More

West Coast Nature Awards for Mentoring in Science: nominations due Aug. 8

The guidance and support mentors provide in labs is too often overlooked. In response, in 2005 Nature created an award aimed at recognizing outstanding scientific mentorship which recognizes different regions of the world each year. This year’s Nature Awards for Mentoring in Science will go to exceptional mentors from the US West Coast states – Washington, Oregon, and California – and nominations are now open. Two prizes of $10,000 will be awarded, one for a mid-career mentor … Read More

Heads up: new required attachment for NIH F series applications

If you are a graduate student or postdoctoral fellow who is planning to apply for an F30, F31, or F32 (otherwise known as NRSAs), you should be aware of a new required attachment, “Description of Institutional Environment and Commitment to Training.”  This new requirement as of May 25, 2016 calls for a new 2-page attachment that documents the institutional resources devoted to career enhancement and the overall intellectual environment. This new attachment also encompasses the … Read More

Outcomes for second-time R01 resubmissions

It’s been over two years since the NIH revised their grant resubmission policy. This revision allows applicants whose R01 application (called an A0) and subsequent resubmission (an A1) are unsuccessful to submit a new application without having to demonstrate significant changes in scientific direction from the previously reviewed applications. When the policy went into effect in April of 2014, there was a sigh of relief but also uncertainty about how these “new” applications, now referred to as … Read More

Few spots remaining for summer Vollum Scientific Writing Course

The Vollum Writing Class is a six-week professional science writing course open to OHSU graduate students, postdoctoral fellows, and faculty. This class uses short lectures, class discussion, and workshop-style writing assignments to help researchers learn to write better papers and grants. Topics include: The basic elements of good scientific writing style, including sentence and document structure Insight into scientific conventions regarding grammar, punctuation, and usage Strategies for revising Dealing with writer’s block and time management Best practices for … Read More

Federal overtime changes will affect universities

This week, the White House announced new federal regulations concerning pay for most classes of workers who make up to $47,476 per year. Specifically, it increases the salary threshold for overtime pay–if you are salaried and make up to $913 per week, you need to receive overtime pay if you work more than 40 hours per week. National Institutes of Health director Francis Collins and Thomas Perez, the U.S. Secretary of Labor, co-authored an article stating … Read More

Marc Freeman to join Vollum Institute as director

Marc Freeman, Ph.D., Howard Hughes Medical Investigator, and professor and vice chair of the Department of Neurobiology at the University of Massachusetts Medical School, will join OHSU as director of the Vollum Institute. Dr. Freeman received his M.Phil. and his Ph.D. in biology from Yale University. He carried out his doctoral training in the laboratory of John Carlson at Yale, where he studied Drosophila olfaction. He then trained as a postdoctoral associate with Chris Q. … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.